Alexander J Gill1, Shreya Gandhy1, Eric Lancaster1. Show Affiliations » 1. Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 19104, Pennsylvania.
Abstract
Entities: Chemical Disease Species
Mesh： See more » Amifampridine/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useCalcium Channels, P-TypeCalcium Channels, Q-TypeCerebellar Diseases/chemically inducedCerebellar Diseases/drug therapyCerebellar Diseases/immunologyCerebellar Diseases/physiopathologyCerebellar Neoplasms/secondaryCerebellar Neoplasms/therapyFemaleGlucocorticoids/therapeutic useHumansImmune Checkpoint Inhibitors/adverse effectsImmunoglobulins, Intravenous/therapeutic useImmunologic Factors/therapeutic useLambert-Eaton Myasthenic Syndrome/chemically inducedLambert-Eaton Myasthenic Syndrome/drug therapyLambert-Eaton Myasthenic Syndrome/immunologyLambert-Eaton Myasthenic Syndrome/physiopathologyLung Neoplasms/diagnostic imagingLung Neoplasms/pathologyLung Neoplasms/therapyLymph Nodes/diagnostic imagingMagnetic Resonance ImagingMiddle AgedNerve Degeneration/chemically inducedNerve Degeneration/drug therapyNerve Degeneration/immunologyNerve Degeneration/physiopathologyNeuroendocrine Tumors/secondaryNeuroendocrine Tumors/therapyNeuromuscular Agents/therapeutic useNivolumab/adverse effectsPositron Emission Tomography Computed TomographyPrednisone/therapeutic useRadiosurgeryRadiotherapyRituximab/therapeutic useSmall Cell Lung Carcinoma/diagnostic imagingSmall Cell Lung Carcinoma/secondarySmall Cell Lung Carcinoma/therapyTomography, X-Ray Computed
Substances： See more » Calcium Channels, P-TypeCalcium Channels, Q-TypeGlucocorticoidsImmune Checkpoint InhibitorsImmunoglobulins, IntravenousImmunologic FactorsNeuromuscular AgentsNivolumabRituximabAmifampridinePrednisone
Year: 2020 PMID： 33290581 DOI： 10.1002/mus.27141
Source DB: PubMed Journal: Muscle Nerve ISSN： 0148-639X Impact factor: 3.217